The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
November 21st 2024
The risk of developing interstitial lung disease after immunotherapy was 6.5 times higher in individuals with high inflammation.
Common Surgical Procedures Account for High Share of Opioid Prescriptions in Children and Adults
July 11th 2024In pediatric and adult patients, the top 3 surgical procedures accounted for the highest share of opioid prescriptions, indicating a need for better opioid prescription management and greater awareness of the possible opioid-related adverse events that can stem from prescriptions of the drug.
Read More
FTC Intends to Sue Biggest Pharmacy Benefit Managers for Unfair Negotiating Tactics
July 11th 2024In a follow-up to the interim FTC report documenting the business practices of PBMs and the power they hold in the pharmaceutical industry, the Commission now seeks to sue the 3 largest PBMs in the country for driving up the price of insulin and other essential drugs.
Read More
High-Dose Intravenous Immunoglobulin Responsive to Platelet-Activating Anti-PF4 Disorder
July 11th 2024Intravenous immunoglobulin was effective as an adjunctive treatment to anticoagulation in a patient with post-viral platelet-activating anti-PF4 disorder, indicating the need for accurate diagnosis and treatment selection.
Read More
Brexanolone and Zuranolone for the Treatment of Postpartum Depression
July 9th 2024The American College of Clinical Gynecology recommends consideration of brexanolone or zuranolone in postpartum patients with onset of moderate-to-severe perinatal depression in the third trimester or within 4 weeks postpartum.
Read More
Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials
July 6th 2024Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.
Read More
Insights on the UK's MHRA International Recognition Procedure
The UK’s Medicine and Healthcare Products Regulatory Agency (MHRA) introduced changes to streamline its drug approval processes.
Read More
Pharmacists Play Essential Role in Managing Dupilumab for Chronic Obstructive Pulmonary Disease
July 3rd 2024As dupilumab garners positive clinical trial results in patients with chronic obstructive pulmonary disease, it is increasingly important that pharmacists educate themselves on the treatment.
Read More